Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer
Man Luo, Man Luo, Man Luo, Jiang Zhu et al. • Frontiers in Pharmacology
(2025)
BackgroundDrug repurposing has emerged as a promising approach for discovering novel anticancer therapeutics. In this study, we systematically investigated the antitumor potential of fedratinib, a JAK2 inhibitor approved for myelofibrosis, ...
DOAJ
Open Access (DOAJ)
DOI:
10.3389/fphar.2025.1689663